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###### 

Analgesia sparing effect with Dexmedetomidine

  Opioid sparing with Dexmedetomidine                               
  ------------------------------------- ------------- ------------- -------
  Fentanyl (μg/Kg)                      166 ± 85      75 ± 48       0.001
                                                                    
  Remifentanil (μg/kg/Min)              0.15 ± 0.09   0.06 ± 0.05   0.001
                                                                    

###### 

Requirement of rescue sedation

  Required rescue sedatives                                                 
  --------------------------- ------------ ----------- ---------- --------- -------
  0.2 (μg/Kg/Hour)            5(1.1%)      0           0          0         
                                                                            
  0.2--0.5 (μg/Kg/Hour)       83(21.1%)    0           0          0         
                                                                            
  0.5--0.7 (μg/Kg/Hour)       96(24.9%)    1(3.3%)     1(3.3%)    0         
                                                                            
  0.5--1.4 (μg/Kg/Hour)       202(52.3%)   29(96.7%)   9(75%)     1(100%)   0.001
                                                                            
  Total                       386(90%)     30(7%)      12(2.8%)   1(0.2%)   0.001
                                                                            
